Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype–phenotype correlations and diagnostic guidelines based on new cases and overview of the literature
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Pontocerebellar hypoplasia type 1 (PCH1) is a major cause of non-5q spinal muscular atrophy (SMA). We screened 128 SMN1-negative SMA patients from Bulgaria for a frequent mutation -p.G31A in EXOSC3, and performed a literature review of all genetically verified PCH1 cases. Homozygous p.G31A/EXOSC3 mutation was identified in 14 Roma patients, representing three fourths of all our SMN1-negative Roma SMA cases. The phenotype of the p.G31A/EXOSC3 homozygotes was compared to the clinical presentation of all reported to date genetically verified PCH1 cases. Signs of antenatal onset of disease present at birth were common in all PCH1 sub-types except in the homozygous p.D132A/EXOSC3 patients. The PCH1sub-types with early death (between ages 1 day and 17 months), seen in patients with p.G31A/EXOSC3 or SLC25A46 mutations have a SMA type 1-like clinical presentation but with global developmental delay, visual and hearing impairment, with or without microcephaly, nystagmus and optic atrophy. Mutations with milder presentation (homozygous p.D132A/EXOSC3 or VRK1) may display additionally signs of upper motor neuron impairment, dystonia or ataxia and die at age between 5 and 18 years. Other EXOSC3 mutations and EXOSC8 cases are intermediate - SMA type 1-like presentation, spasticity (mostly in EXOSC8) and death between 3 months and 5 years. There is no correlation between neurological onset and duration of life. We add marble-like skin and congenital laryngeal stridor as features of PCH1. We show that imaging signs of cerebellar and pontine hypoplasia may be missing early in infancy. EMG signs of anterior horn neuronopathy may be missing in PCH1 patients with SLC25A46 mutations. Thus, there is considerable phenotypic variability in PCH1, with some cases being more SMA-like, than PCH-like. Detailed clinical evaluation and ethnicity background may guide genetic testing and subsequent genetic counseling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For EXOSC8, a phenotype-genotype correlation was suggested for several missense variants, with substitutions such as EXOSC8 p.Ser272Thr associated with respiratory failure and death in the second year of life, whereas other missense variants were linked to longer survival (51).”
From Biallelic variants in the RNA exosome gene EXOSC5 are associated with developmental delays, short stature, cerebellar hypoplasia and motor weakness (2020) · cites this paper as [51]
In the citing paper
“In contrast, compound heterozygosity for EXOSC3 p.Asp132Ala with an EXOSC3 nonsense variant or the EXOSC3 p.Tyr109Asn allele or homozygosity for EXOSC3 p.Gly31Ala or p.Gly135Glu causes attenuation of the ventral pons and more rapid clinical progression (51).”
From Biallelic variants in the RNA exosome gene EXOSC5 are associated with developmental delays, short stature, cerebellar hypoplasia and motor weakness (2020) · cites this paper as [51]
In the citing paper
“For EXOSC3, homozygosity for p.Asp132Ala results in a milder phenotype with preservation of the pons and the potential for survival into early puberty.”
From Biallelic variants in the RNA exosome gene EXOSC5 are associated with developmental delays, short stature, cerebellar hypoplasia and motor weakness (2020) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deep sequencing reveals 50 novel genes for recessive cognitive disorders
Najmabadi, H., Hu, H., Garshasbi, M., Zemojtel, T., Abedini, S. S., Chen, W., Hosseini, M., Behjati, F., Haas, S., Jamali, P., et al. (2011) · Nature · doi:10.1038/nature10423 · Cited by 965
Wan, J., Yourshaw, M., Mamsa, H., Rudnik-Schöneborn, S., Menezes, M. P., Hong, J. E., Leong, D. W., Senderek, J., Salman, M. S., Chitayat, D., et al. (2012) · Nature Genetics · doi:10.1038/ng.2254 · Cited by 257
Boczonadi, V., Müller, J. S., Pyle, A., Munkley, J., Dor, T., Quartararo, J., Ferrero, I., Karcagi, V., Giunta, M., Polvikoski, T., et al. (2014) · Nature Communications · doi:10.1038/ncomms5287 · Cited by 149
Novel EXOSC3 mutation causes complicated hereditary spastic paraplegia
Halevy, A., Lerer, I., Cohen, R., Kornreich, L., Shuper, A., Gamliel, M., Zimerman, B.-E., Korabi, I., Meiner, V., Straussberg, R., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7457-x · Cited by 46
Schwabova, J., Brozkova, D. S., Petrak, B., Mojzisova, M., Pavlickova, K., Haberlova, J., Mrazkova, L., Hedvicakova, P., Hornofova, L., Kaluzova, M., et al. (2013) · Journal of Neurogenetics · doi:10.3109/01677063.2013.814651 · Cited by 44
Zanni, G., Scotton, C., Passarelli, C., Fang, M., Barresi, S., Dallapiccola, B., Wu, B., Gualandi, F., Ferlini, A., Bertini, E., et al. (2013) · neurogenetics · doi:10.1007/s10048-013-0371-z · Cited by 41
Cited by
Slavotinek, A., Misceo, D., Htun, S., Mathisen, L., Frengen, E., Foreman, M., Hurtig, J. E., Enyenihi, L., Sterrett, M. C., Leung, S. W., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa108 · Cited by 38
Bi‐allelic missense variant, p. Ser35Leu in EXOSC1 is associated with pontocerebellar hypoplasia
Somashekar, P. H., Kaur, P., Stephen, J., Guleria, V. S., Kadavigere, R., Girisha, K. M., Bielas, S., Upadhyai, P., & Shukla, A. (2021) · Clinical Genetics · doi:10.1111/cge.13928 · Cited by 32
“These findings are similar to those observed in PCH type 1.(16) Phenotypic and genotypic comparison of exosome complex related disorders are provided in the Table 1.”
ResultSakamoto, M., Iwama, K., Sekiguchi, F., Mashimo, H., Kumada, S., Ishigaki, K., Okamoto, N., Behnam, M., Ghadami, M., Koshimizu, E., et al. (2021) · Journal of Human Genetics · doi:10.1038/s10038-020-00853-2 · Cited by 26
Morton, D. J., Jalloh, B., Kim, L., Kremsky, I., Nair, R. J., Nguyen, K. B., Rounds, J. C., Sterrett, M. C., Brown, B., Le, T., et al. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1008901 · Cited by 24
“Furthermore, the spectrum of phenotypes observed in flies expressing alleles of PCH1b aligns with some aspects of genotype-phenotype correlations reported for individuals with PCH1b [29, 35], suggesting that these amino acid changes differentially impact RNA”
BackgroundInfluentialde Amorim, J. L., Leung, S. W., Haji-Seyed-Javadi, R., Hou, Y., Yu, D. S., Ghalei, H., Khoshnevis, S., Yao, B., & Corbett, A. H. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105646 · Cited by 20
Metadata
- Authors
- Ivanov, I., Atkinson, D., Litvinenko, I., Angelova, L., Andonova, S., Mumdjiev, H., Pacheva, I., Panova, M., Yordanova, R., Belovejdov, V., Petrova, A., Bosheva, M., Shmilev, T., Savov, A., & Jordanova, A.
- Venue
- European Journal of Paediatric Neurology
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 22
- Issue
- 4
- Pages
- 674-681
- ISSN
- 1090-3798 (ISSN-L)
- OpenAlex
- W2796297886
- Cited by
- 32
- References
- 6
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.